2 recruiting, 1 enrolling by invitation. 2 Phase 3, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 2 |
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Man Hu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial Intensity-Modulated Proton Therapy (IMPT), Intensity-Modulated Radiation Therapy (IMRT), Cisplatin - Nasopharyngeal Carcinoma (NPC) | Phase 3 | Recruiting | Man Hu | 300 | 2025-12-15 | 2026-01-14 |
| Phase III Non-Inferiority Trial of Proton Versus Photon Therapy for Nasopharyngeal Carcinoma Intensity-Modulated Proton Therapy (IMPT), Intensity-Modulated Radiotherapy (IMRT) - Nasopharyngeal Carcinoma | Phase 3 | Recruiting | Man Hu | 386 | 2025-05-07 | 2025-06-03 |
| Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors PET/CT （[18F]AlF-NOTA-PCP2）, [18F]AlF-NOTA-PCP2 PET/CT Imaging for PD-L1 Expression in Malignant Tumors - Glioblastoma (GBM), Head and Neck Squamous Cell Carcinoma | Phase 1 / Phase 2 | Enrolling by invitation | Man Hu | 100 | 2024-03-30 | 2025-03-30 |
Nasopharyngeal Carcinoma (2) · Carcinoma, Non-Small-Cell Lung (1) · Esophageal Neoplasms (1) · Glioblastoma (1) · Squamous Cell Carcinoma of Head and Neck (1)
Radiotherapy, Intensity-Modulated (2) · Cisplatin (1) · toripalimab (1)
China (3)